병원내 감염 관리 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Hospital Acquired Infection Control Market Growth & Trends:

The global hospital acquired infection control market size is anticipated to reach USD 9.03 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 5.2% from 2024 to 2030. The key factors driving the market growth include the rising incidence of Hospital Acquired Infections (HAIs), supportive government initiatives, and the COVID-19 pandemic. The COVID-19 pandemic has emerged as a major catalyst for the market as it led to increased awareness and concern over HAIs. The demand for infection control equipment and consumables also stemmed from the need to stop the spread of COVID-19.

Governments and regulatory bodies prescribed several policies and guidelines to prevent cross-contamination and safeguard public health. To prevent nosocomial infections in healthcare facilities, infection control standards were implemented such as triage strategy and provision and proper distribution of equipment, in addition to standard precautions such as hand washing and use of personal protective equipment. In particular, the pandemic resulted in a surge in demand for consumables such as PPE, masks, and disinfectants.

The CDC, of the U.S. Department of Health and Human Services, provides an extensive library of guidelines on basic infection prevention and control, antibiotic resistance, device-associated infections, procedure-associated infections, and disease / organism-specific to promote the control of HAIs. In the wake of the pandemic, the CDC added COVID-19 infection control guidelines to its digital library.

Growing initiatives by market players also contribute to the growth of the market. These initiatives include strategic partnerships, mergers and acquisitions, and product development. In February 2021, for instance, Getinge expanded its partnership with XPO Logistics under which the latter will provide warehousing and transport services from the Netherlands to the EMEA region for the company's infection control business unit. In December 2020, Xenex launched LightStrike 6 as part of its patented lineup of pathogen-eliminating robots. The robots produce high-intensity broad-spectrum UV light and can also deactivate the COVID-19 virus in 2 minutes.

Hospital Acquired Infection Control Market Report Highlights:

• The consumables segment dominated the market and accounted for the largest revenue share of 46.9% in 2023. This was owing to the high usage of consumables in hospitals and ambulatory care centers. The COVID-19 pandemic further contributed to the segment share due to the increased need for disposable, safe, and effective solutions to curb the spread of the virus. These included products such as N95 masks, PPE, and gloves
• The hospitals and Intensive Care Units (ICUs) segment held the largest revenue share of 45.9% in 2023 due to the high prevalence of healthcare-associated infections (HCAIs) in these facilities. According to CDC estimates, about 1 out of 31 hospital patients suffer from at least one HAI on any given day
• In Asia Pacific, the market is anticipated to witness lucrative growth in coming years owing to increasing supportive government initiatives to promote HAIs control products in the region
• Strategic initiatives by market players are mergers and acquisitions, collaboration, geographic expansions, and new product development. For example, in November 2020, Getinge acquired a manufacturer of decontamination products-Quadralene. The company was merged into Getinge's Infection Control portfolio to expand its offerings in the business area of Surgical Workflows

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Hospital Acquired Infection Control Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Hospital Acquired Infection Control Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1 Bargaining power of the suppliers
    • 3.4.1.2 Bargaining power of the buyers
    • 3.4.1.3 Threats of substitution
    • 3.4.1.4 Threats from new entrants
    • 3.4.1.5 Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1 Political landscape
    • 3.4.2.2 Economic and Social landscape
    • 3.4.2.3 Technological landscape
    • 3.4.2.4 Environmental landscape
    • 3.4.2.5 Legal landscape

Chapter 4. Hospital Acquired Infection Control Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Hospital Acquired Infection Control Market: Type Movement Analysis, 2023 & 2030 (USD Million)
• 4.3. Equipment
  • 4.3.1. Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.2. Sterilization Equipment
    • 4.3.2.1 Sterilization Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2.2 Heat Sterilization Equipment
      • 4.3.2.2.1. Heat Sterilization Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.2.2. Moist Heat Sterilization
        • 4.3.2.2.2.1. Moist Heat Sterilization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2.3. Dry Heat Sterilization
      • 4.3.2.3.1. Dry Heat Sterilization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.3 Low Temperature Sterilization
    • 4.3.3.1. Low Temperature Sterilization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.4 Radiation Sterilization
    • 4.3.4.1. Radiation Sterilization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.5 Others
    • 4.3.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.6. Disinfection Equipment
    • 4.3.6.1 Disinfection Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6.2 Washer Disinfector
      • 4.3.6.2.1 Washer Disinfector Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.7 Flusher Disinfector
    • 4.3.7.1. Flusher Disinfector Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.7.2 Endoscopic Reprocessor Systems
      • 4.3.7.2.1 Endoscopic Reprocessor Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Services
  • 4.4.1. Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Disinfectants
    • 4.5.2.1 Disinfectants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Sterilization Consumables
    • 4.5.3.1 Sterilization Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Others
    • 4.5.4.1 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Hospital Acquired Infection Control Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Hospital Acquired Infection Control Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
• 5.3. Hospitals and Intensive Care Units (ICUs)
  • 5.3.1. Hospitals and Intensive Care Units (ICUs) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Ambulatory Surgical and Diagnostic Centers
  • 5.4.1. Ambulatory Surgical and Diagnostic Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Others
  • 5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hospital Acquired Infection Control Market: Regional Estimates & Trend Analysis

• 6.1. Hospital Acquired Infection Control Market Share, By Region, 2023 & 2030 (USD Million)
• 6.2. North America
  • 6.2.1. North America Hospital Acquired Infection Control Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Hospital Acquired Infection Control Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Hospital Acquired Infection Control Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. China
    • 6.4.3.1 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. Australia
    • 6.4.5.1 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. South Korea
    • 6.4.6.1 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. Thailand
    • 6.4.7.1 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Hospital Acquired Infection Control Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East & Africa (MEA)
  • 6.6.1. MEA Hospital Acquired Infection Control Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. 3M Company
    • 7.4.1.1 Participant's Overview
    • 7.4.1.2 Financial Performance
    • 7.4.1.3 Product Benchmarking
    • 7.4.1.4 Recent Developments/Strategic Initiatives
  • 7.4.2. Belimed AG
    • 7.4.2.1 Participant's Overview
    • 7.4.2.2 Financial Performance
    • 7.4.2.3 Product Benchmarking
    • 7.4.2.4 Recent Developments/Strategic Initiatives
  • 7.4.3. O&M Halyards
    • 7.4.3.1 Participant's Overview
    • 7.4.3.2 Financial Performance
    • 7.4.3.3 Product Benchmarking
    • 7.4.3.4 Recent Developments/Strategic Initiatives
  • 7.4.4. Getinge
    • 7.4.4.1 Participant's Overview
    • 7.4.4.2 Financial Performance
    • 7.4.4.3 Product Benchmarking
    • 7.4.4.4 Recent Developments/Strategic Initiatives
  • 7.4.5. ASP
    • 7.4.5.1 Participant's Overview
    • 7.4.5.2 Financial Performance
    • 7.4.5.3 Product Benchmarking
    • 7.4.5.4 Recent Developments/Strategic Initiatives
  • 7.4.6. Sterigenics U.S., LLC - A Sotera Health Company
    • 7.4.6.1 Participant's Overview
    • 7.4.6.2 Financial Performance
    • 7.4.6.3 Product Benchmarking
    • 7.4.6.4 Recent Developments/Strategic Initiatives
  • 7.4.7. MMM Group
    • 7.4.7.1 Participant's Overview
    • 7.4.7.2 Financial Performance
    • 7.4.7.3 Product Benchmarking
    • 7.4.7.4 Recent Developments/Strategic Initiatives
  • 7.4.8. Cantel Medical Corp. (Medivators Inc.)
    • 7.4.8.1 Participant's Overview
    • 7.4.8.2 Financial Performance
    • 7.4.8.3 Product Benchmarking
    • 7.4.8.4 Recent Developments/Strategic Initiatives
  • 7.4.9. Midmark Corporation
    • 7.4.9.1 Participant's Overview
    • 7.4.9.2 Financial Performance
    • 7.4.9.3 Product Benchmarking
    • 7.4.9.4 Recent Developments/Strategic Initiatives
  • 7.4.10. STERIS
    • 7.4.10.1 Participant's Overview
    • 7.4.10.2 Financial Performance
    • 7.4.10.3 Product Benchmarking
    • 7.4.10.4 Recent Developments/Strategic Initiatives
  • 7.4.11. W&H
    • 7.4.11.1 Participant's Overview
    • 7.4.11.2 Financial Performance
    • 7.4.11.3 Product Benchmarking
    • 7.4.11.4 Recent Developments/Strategic Initiatives